Overview
- Four-month data presented at the ASTRO meeting showed 70% of patients receiving 3 Gy over six sessions met responder criteria versus 42% with sham treatment (p=0.014).
- The multicenter randomized trial enrolled 114 people with primary knee osteoarthritis and assigned them to 3 Gy, 0.3 Gy, or sham across six sessions.
- The very low-dose 0.3 Gy arm did not differ significantly from sham, indicating the therapeutic effect was driven by the 3 Gy dose.
- No radiation-related side effects were reported, and investigators noted the regimen uses a small fraction of doses typical in cancer care.
- Researchers restricted analgesics to acetaminophen during follow-up to limit confounding, and they are completing 12-month assessments with larger and comparative trials planned.